Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Priyathersini Nagarajan"'
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 15, Iss 4, Pp EC27-EC32 (2021)
Introduction: Matrix Metalloproteinase-2 (MMP-2) is over expressed in a variety of malignant tumours and their expression and activity are often associated with tumour aggressiveness and a poor prognosis. It serves as a prognostic marker in breast
Externí odkaz:
https://doaj.org/article/ca0f12a08e6f47e7803a76c85baf2107
Publikováno v:
Journal of Applied Hematology, Vol 7, Iss 3, Pp 111-113 (2016)
Acute myeloid leukemia (AML) M6 or acute erythroid leukemia is an extremely rare type of AML accounting for 3–4% of all AML cases. In children, AML is even rarer, in accordance to the fact that only 0.5–4.6% of all cancer-affected individuals are
Externí odkaz:
https://doaj.org/article/d4ba39b2aeb54ea3ada880932430abab
Publikováno v:
Biomedicine. 41:638-643
Introduction and Aim:HaemophagocyticLymphohistiocytic Syndrome (HLH) is a fatal disease with characteristic proliferation of histiocytes in the organs including bone marrow, liver, spleen, kidney, csf, meninges, lymph nodes and subcutaneous tissue wh
Publikováno v:
Biomedicine. 41
Introduction and Aim: Haemophagocytic Lymphohistiocytic Syndrome (HLH) is a fatal disease with characteristic proliferation of histiocytes in the organs including bone marrow, liver, spleen, kidney, csf, meninges, lymph nodes and subcutaneous tissue
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 15, Iss 4, Pp EC27-EC32 (2021)
Introduction: Matrix Metalloproteinase-2 (MMP-2) is over expressed in a variety of malignant tumours and their expression and activity are often associated with tumour aggressiveness and a poor prognosis. It serves as a prognostic marker in breast ca
Publikováno v:
Journal of Applied Hematology, Vol 7, Iss 3, Pp 111-113 (2016)
Acute myeloid leukemia (AML) M6 or acute erythroid leukemia is an extremely rare type of AML accounting for 3–4% of all AML cases. In children, AML is even rarer, in accordance to the fact that only 0.5–4.6% of all cancer-affected individuals are
Autor:
Shanmugam, Sri Gayathri, Priyathersini, Nagarajan, Muralikrishnan, Srikanth, Balasubramanian, Archana
Publikováno v:
In Hematology, Transfusion and Cell Therapy October-December 2020 42(4):376-380
Autor:
Ramamoorthy P; Department of Pathology, Sri Ramachandra Institute of Higher Education and Research, Chennai, IND., Priyathersini N; Department of Pathology, Sri Ramachandra Institute of Higher Education and Research, Chennai, IND., M D; Department of Pathology, Sri Ramachandra Institute of Higher Education and Research, Chennai, IND., Duraisamy M; Department of Obstetrics and Gynecology, Sri Ramachandra Institute of Higher Education and Research, Chennai, IND.
Publikováno v:
Cureus [Cureus] 2024 Sep 22; Vol. 16 (9), pp. e69893. Date of Electronic Publication: 2024 Sep 22 (Print Publication: 2024).
Autor:
Srinivas S; College of Medicine, Sri Ramachandra Institute of Higher Education and Research, Chennai, IND., Priyathersini N; Pathology, Sri Ramachandra Medical College and Research Institute, Chennai, IND., Balasubramanian A; Pathology, Sri Ramachandra Institute of Higher Education and Research, Chennai, IND., Raj D R; General Surgery, Sri Ramachandra Institute of Higher Education and Research, Chennai, IND.
Publikováno v:
Cureus [Cureus] 2024 Sep 21; Vol. 16 (9), pp. e69847. Date of Electronic Publication: 2024 Sep 21 (Print Publication: 2024).
Autor:
Thillai Arunachalam NS; Pathology, Sri Ramachandra Institute of Higher Education and Research, Chennai, IND., N S; Pathology, Sri Ramachandra Institute of Higher Education and Research, Chennai, IND., Priyathersini N; Pathology, Sri Ramachandra Institute of Higher Education and Research, Chennai, IND., M A; Pathology, Sri Ramachandra Institute of Higher Education and Research, Chennai, IND., Kajamohideen S; Surgical Oncology, Sri Ramachandra Institute of Higher Education and Research, Chennai, IND.
Publikováno v:
Cureus [Cureus] 2023 Apr 18; Vol. 15 (4), pp. e37750. Date of Electronic Publication: 2023 Apr 18 (Print Publication: 2023).